Perbal Bernard
Université Côte d'Azur, CNRS, GREDEG, International CCN Society, Nice, France.
J Cell Commun Signal. 2018 Mar;12(1):3-12. doi: 10.1007/s12079-018-0455-5. Epub 2018 Feb 22.
The wide array of biological properties attributed to the CCN family of proteins (Perbal in Lancet 363(9402):62-64, 2004) led me to reconsider the possible relationship and roles that these proteins may play as a team, instead of acting on their own as individual regulators in various signaling pathways. The dynamic model which I present in this review stems from the contribution of the biological properties that we established for CCN3, one of the three founding members of the CCN family, which was identified by our group as the first CCN protein showing growth inhibitory properties (1992), expressed mainly in quiescent cells (1996), and showing anti-tumor activities in several cellular models both ex vivo and in vivo. At the present time CCN3 is the only member of the family that has been reported to negatively act on the progression of the cell cycle. The unique dual localisation of CCN3 in the nucleus and outside cells, either at the membrane or in the extracellular matrix, that I first established in 1999, and that now appears to be shared by several other CCN proteins, is a unique essential feature which can no longer be ignored. Based on the structural and functional properties of CCN3, shared by most of the CCN family members, I propose an « all in one » concept in which CCN proteins are team members with specific functions that are aimed at the same goal. This model accounts both for the functional specificity of the various CCN proteins, their sequential and opposite or complementary effects in various biological context, and for the biological consequences of their physical interaction and biological cross-regulation.
CCN蛋白家族具有广泛的生物学特性(佩尔巴尔,《柳叶刀》363(9402):62 - 64,2004年),这使我重新思考这些蛋白作为一个团队可能发挥的关系和作用,而不是在各种信号通路中各自作为独立的调节因子发挥作用。我在本综述中提出的动态模型源于我们为CCN3确定的生物学特性,CCN3是CCN家族的三个创始成员之一,被我们团队鉴定为首个具有生长抑制特性的CCN蛋白(1992年),主要在静止细胞中表达(1996年),并在多种体外和体内细胞模型中显示出抗肿瘤活性。目前,CCN3是该家族中唯一被报道对细胞周期进程有负向作用的成员。我于1999年首次确定的CCN3在细胞核以及细胞外(细胞膜或细胞外基质)的独特双重定位,现在看来其他几种CCN蛋白也有这种定位,这是一个不容忽视的独特关键特征。基于大多数CCN家族成员共有的CCN3的结构和功能特性,我提出一个“一体化”概念,即CCN蛋白是具有特定功能的团队成员,它们朝着同一个目标发挥作用。该模型既解释了各种CCN蛋白的功能特异性、它们在不同生物学背景下的相继且相反或互补的作用,也解释了它们物理相互作用和生物学交叉调节的生物学后果。